Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00346489 · ClinicalTrials.gov registry record · Phase 4
Outcomes of Intraoperative 5-Fluorouracil Versus Mitomycin C
A Phase 4 study, sponsored by Indiana University.
- Completed
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
NCT00346489 is a Phase 4 study that has completed, run by Indiana University. The registered enrollment target is 70 participants.
The verdict
NCT00346489, a Phase 4 study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
Study Summary
A clinical trial to establish the long term response of using intraoperative 5-fluorouracil (5-FU) versus mitomycin C (MMC) in trabeculectomy glaucoma surgery. Antiproliferative agents such as 5-fluorouracil and Mitomycin C have been used extensively in trabeculectomy surgery to improve the success of the surgery and prevent further visual loss and blindness in glaucoma patients.
Interventions
- DRUG 5-fluorouracil
- DRUG Mitomycin C
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2004-09 |
| Est. Completion | 2007-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00346489
The ClinicalTrials.gov registry entry for NCT00346489 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 5-fluorouracil is the first listed.
NCT00346489 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00346489 about?
NCT00346489 is a clinical study titled "Outcomes of Intraoperative 5-Fluorouracil Versus Mitomycin C". A clinical trial to establish the long term response of using intraoperative 5-fluorouracil (5-FU) versus mitomycin C (MMC) in trabeculectomy glaucoma surgery. Antiproliferative agents such as 5-fluorouracil and Mitomycin C have been used extensively in trabeculectomy surgery to improve the success ...
What is the current status of trial NCT00346489?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2004-09. Estimated completion is 2007-08.
What interventions are being tested in trial NCT00346489?
The interventions under investigation include: 5-fluorouracil (DRUG), Mitomycin C (DRUG).
Who is sponsoring clinical trial NCT00346489?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.